ABSTRACThydrocephalus following cranial surgery is a well-recognized phenomenon (29) and results from a combination of collateral damage incurred during the surgical procedure (19) and the alterations occurring later in the CSF circulation, cerebral blood flow (CBF) auto-regulation and cerebral compliance (47).Complications resulting from VP shunts are notoriously common (7,9,13,24) and have been a subject of extensive research. (26, 27, 51) However, only a few studies have focused on VP shunt survival in patients who develop hydrocephalus as a consequence of cranial surgery itself. In this study, we report our experience of managing post-cranial surgery hydrocephalus in both pediatric and adult patients with particular emphasis on shunt complications and factors influencing shunt survival.
█ INTRODUCTIONHydrocephalus results from abnormal production, flow or absorption of cerebrospinal fluid (CSF) causing an "active distension" of ventricles of the brain (40). Left untreated, this condition can lead to rapid deterioration and adverse long-term outcomes, both in pediatric (45) and adult (28) patients. Prompt CSF diversion with ventriculoperitoneal (VP) shunt insertion remains the most popular treatment for hydrocephalus (17).A number of classification schemes have been proposed to categorize hydrocephalus (3,22,32,33,37). However, no single scheme is comprehensive enough to encompass all aspects of this diverse entity (40). The development of AIM: Ventriculoperitoneal (VP) shunt insertion remains the most popular method for the treatment of hydrocephalus despite its associated complications. We assessed VP shunt survival in a group of patients who had developed hydrocephalus following cranial surgery.
MATERIAL and METHODS:A retrospective charts review was done over a 10-year period at our institution. Kaplan-Meier survival curves and Log-Rank (Cox-Mantel) test were used to analyze various factors affecting VP shunt survival.
RESULTS:Among the 67 cases included, a total of 28 (46.3%) patients had undergone cranial surgery for brain tumors. The overall rate of shunt failure was 14.9% at a mean follow-up of 16 months. Shunt failure in pediatric patients (20%) was slightly higher than that in adult patients (13.5%). The median time to first shunt failure was adversely influenced by a history of brain tumor (p = 0.019), prolonged antibiotic therapy (p = 0.018) and administration of steroids (p = 0.004).CONCLUSION: Shunt survival was worse in patients who developed hydrocephalus following cranial surgery performed for brain tumors and those who received either steroids or prolonged antibiotic therapy. Thus post-cranial surgery hydrocephalus represents a unique subset of hydrocephalus.